US$ 26.78
who makes ozempic semaglutide (semaglutide): Uses, Side Effects, Dosage & More Canada approves first generic version
Description
Severe gastrointestinal disease, particularly gastroparesis, may worsen with GLP-1 agonist therapy

Knowing when to seek help is also key
It's an investigational drug in Phase 3 clinical trials

When blood oxygen delivery to your brain decreases, lightheadedness often follows

The drug has totally ruined my appetite and when I do eat I feel full really quickly
